ngs for mrd detection in leukemia
Published 2 years ago • 184 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
2:00
mrd detection with ngs for aml: a new era of diagnostics
-
2:15
mass spectrometry, ngs & ngf for mrd detection in multiple myeloma
-
0:48
pre-measure study: assessing the role of ngs mrd in patients with aml receiving sct
-
1:56
ngs vs flow cytometry for mrd assessment in npm1-mutated aml
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
10:20
next-generation sequencing for oncologists
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
16:38
ngs for myeloid neoplasm evaluation
-
2:20
ngs and high sensitivity ddpcr for detecting mrd
-
2:51
mrd testing in acute leukemias
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
1:55
assessing flt3-itd-specific mrd clearance using a pcr-ngs assay in the quantum-first trial
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
0:57
how reliable is ngs in diagnosing aml?
-
2:22
next-generation methodologies: the future for mrd monitoring in all?
-
1:06
mrd evaluation by mfc and ngs for mm
-
3:02
mrd monitoring by ngs in aml over time: revealing predictors of relapse
-
2:43
veneto-stop: mrd detection by ngs to optimize treatment outcomes with venetoclax
-
2:22
molecular mrd detection in aml
-
3:43
ngs screening for novel mrd tracking markers in the foll12 trial
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
1:41
novel technologies to detect minimal residual disease (mrd)